Cargando…
Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer’s mouse model
BACKGROUND: Diabetes is a risk factor for developing Alzheimer’s disease (AD); however, the mechanism by which diabetes can promote AD pathology remains unknown. Diabetes results in diverse molecular changes in the brain, including dysregulation of glucose metabolism and loss of cerebrovascular home...
Autores principales: | Sankar, Sitara B., Infante-Garcia, Carmen, Weinstock, Laura D., Ramos-Rodriguez, Juan Jose, Hierro-Bujalance, Carmen, Fernandez-Ponce, Cecilia, Wood, Levi B., Garcia-Alloza, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988295/ https://www.ncbi.nlm.nih.gov/pubmed/31992349 http://dx.doi.org/10.1186/s12974-020-1707-x |
Ejemplares similares
-
Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models
por: Carranza-Naval, Maria Jose, et al.
Publicado: (2021) -
Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes
por: Vargas-Soria, Maria, et al.
Publicado: (2022) -
In Vivo Imaging of Microglia With Multiphoton Microscopy
por: Hierro-Bujalance, Carmen, et al.
Publicado: (2018) -
Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes
por: Hierro-Bujalance, Carmen, et al.
Publicado: (2020) -
Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
por: Misko, Albert L., et al.
Publicado: (2022)